The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer

BACKGROUND: Treatment of locally advanced squamous cell carcinomas of the head and neck (SCCHN) remains unsatisfactory. Although the addition of concurrent radiochemotherapy (RCT) or the combination of radiotherapy with blockade of the epidermal growth factor receptor (EGFR) have improved outcomes o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers Head Neck
Main Authors: Tinhofer, Ingeborg, Budach, Volker, Jöhrens, Korinna, Keilholz, Ulrich
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6460729/
https://ncbi.nlm.nih.gov/pubmed/31093338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41199-016-0009-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki